It is now clear that melanocytic nevi constitute benign neoplasms of cutaneous melanocytes, which frequently harbour oncogenic serine/threonine-protein kinase B-Raf (BRAF) or, less commonly, neuroblastoma ras viral oncogene homolog (NRAS) mutations. Here, NRAS is linked to benign neoplasm.